Q1 2024 · 13F-HR
Eagle Health Investments LPholdings as filed
Filed 2024-05-14 · accession 0001172661-24-002255
$538.2M
Reported value
27
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 632307104 | NTRA | NATERA INC | $57.9M | 10.8% | 632,714 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $50.3M | 9.34% | 149,590 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $43.8M | 8.13% | 318,754 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $41.2M | 7.66% | 179,499 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $39.5M | 7.34% | 284,918 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $33.3M | 6.19% | 84,590 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $30.8M | 5.73% | 121,895 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $28.4M | 5.27% | 113,685 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $26.2M | 4.88% | 122,203 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $20.6M | 3.83% | 278,655 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $16.7M | 3.10% | 337,218 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $15.1M | 2.80% | 730,209 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $14.7M | 2.74% | 462,911 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $14.2M | 2.64% | 35,590 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $14.0M | 2.60% | 299,700 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $13.4M | 2.49% | 197,000 | PUT | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $13.4M | 2.48% | 103,256 | Common | SOLE |
| 36118A100 | — | FUSION PHARMACEUTICALS INC | $12.4M | 2.30% | 579,769 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $9.7M | 1.80% | 330,830 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $8.4M | 1.55% | 121,000 | Common | SOLE |
| 69404D108 | PACB | PACIFIC BIOSCIENCES CALIF IN | $8.1M | 1.51% | 2,167,021 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $7.2M | 1.34% | 48,356 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $5.1M | 0.94% | 135,059 | Common | SOLE |
| 95075A107 | HOWL | WEREWOLF THERAPEUTICS INC | $4.5M | 0.84% | 700,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $3.7M | 0.69% | 45,000 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $3.0M | 0.56% | 46,300 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $2.7M | 0.50% | 43,200 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.